Similar articles for PMID: 28306694

Year	Number of Results
2012	3
2013	7
2014	9
2015	24
2016	24
2017	23
2018	3
2019	4
2020	2
2021	3
2024	0

1

Real-world use of ticagrelor and prasugrel in patients with NSTEMI undergoing percutaneous coronary intervention.

Sucato V, Corrado E, Castellana C, Carella M, Raso S, Coppola G, Andolina G, Novo G, Evola S, Novo S. Sucato V, et al. J Cardiovasc Med (Hagerstown). 2017 Jun;18(6):450-451. doi: 10.2459/JCM.0000000000000516. J Cardiovasc Med (Hagerstown). 2017. PMID: 28306694 No abstract available.

2

Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting: A Prospective, Randomized, Crossover Trial.

Jeong HS, Hong SJ, Cho SA, Kim JH, Cho JY, Lee SH, Joo HJ, Park JH, Yu CW, Lim DS. Jeong HS, et al. JACC Cardiovasc Interv. 2017 Aug 28;10(16):1646-1658. doi: 10.1016/j.jcin.2017.05.064. JACC Cardiovasc Interv. 2017. PMID: 28838475 Free article. Clinical Trial.

3

Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT).

Déry JP, Mehta SR, Fisher HN, Zhang X, Zhu YE, Welsh RC, Lavi S, Cieza T, Henderson MA, Lutchmedial S, Siega AJ, Cheema AN, Wong BY, Kokis A, Dehghani P, Goodman SG; Canadian Observational AntiPlatelet sTudy (COAPT) Investigators. Déry JP, et al. Am Heart J. 2016 Nov;181:26-34. doi: 10.1016/j.ahj.2016.07.014. Epub 2016 Aug 7. Am Heart J. 2016. PMID: 27823690

4

Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention.

Yudi MB, Clark DJ, Farouque O, Eccleston D, Andrianopoulos N, Duffy SJ, Brennan A, Lefkovits J, Ramchand J, Yip T, Oqueli E, Reid CM, Ajani AE; Melbourne Interventional Group. Yudi MB, et al. Intern Med J. 2016 May;46(5):559-65. doi: 10.1111/imj.13041. Intern Med J. 2016. PMID: 26909472

5

Can new generation P2Y12 inhibitors play a role in microvascular obstruction in STEMI?

Vannini L, Muro A, Sanchis J, Ortiz-Pérez JT, Flores Umanzor E, López-Lereu MP, Badimon L, Sabaté M, Brugaletta S. Vannini L, et al. Int J Cardiol. 2016 Nov 15;223:226-227. doi: 10.1016/j.ijcard.2016.08.182. Epub 2016 Aug 8. Int J Cardiol. 2016. PMID: 27541661 No abstract available.

6

One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database.

Effron MB, Nair KV, Molife C, Keller SY, Page RL 2nd, Simeone JC, Murphy B, Nordstrom BL, Zhu Y, McCollam PL, Vetrovec GW. Effron MB, et al. Am J Cardiovasc Drugs. 2018 Apr;18(2):129-141. doi: 10.1007/s40256-017-0255-y. Am J Cardiovasc Drugs. 2018. PMID: 29222628

7

Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis.

Rafique AM, Nayyar P, Wang TY, Mehran R, Baber U, Berger PB, Tobis J, Currier J, Dave RH, Henry TD. Rafique AM, et al. JACC Cardiovasc Interv. 2016 May 23;9(10):1036-46. doi: 10.1016/j.jcin.2016.02.013. JACC Cardiovasc Interv. 2016. PMID: 27198684 Free article.

8

Head-to-head comparison of prasugrel versus ticagrelor in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.

Sakurai R, Burazor I, Bonneau HN, Kaneda H. Sakurai R, et al. J Interv Cardiol. 2017 Oct;30(5):457-464. doi: 10.1111/joic.12416. Epub 2017 Aug 13. J Interv Cardiol. 2017. PMID: 28804959 Free article.

9

Real-world clopidogrel utilization in acute coronary syndromes: patients selection and outcomes in a single-center experience.

Castini D, Persampieri S, Cazzaniga S, Ferrante G, Centola M, Lucreziotti S, Salerno-Uriarte D, Sponzilli C, Carugo S. Castini D, et al. Ther Adv Cardiovasc Dis. 2017 Dec;11(12):323-331. doi: 10.1177/1753944717738911. Ther Adv Cardiovasc Dis. 2017. PMID: 29134853 Free PMC article.

10

A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis.

Westman PC, Lipinski MJ, Torguson R, Waksman R. Westman PC, et al. Cardiovasc Revasc Med. 2017 Mar;18(2):79-85. doi: 10.1016/j.carrev.2016.10.005. Epub 2016 Oct 21. Cardiovasc Revasc Med. 2017. PMID: 28089137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year